GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 534.00
Bid: 531.00
Ask: 533.00
Change: 7.00 (1.33%)
Spread: 2.00 (0.377%)
Open: 525.00
High: 534.00
Low: 523.00
Prev. Close: 527.00
CRE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

2 Sep 2005 09:42

Creston PLC02 September 2005 2 September 2005 Creston Plc (the "Company")Grant of Options and of Restricted Shares under the Creston Long Term IncentivePlan On 31 August 2005 the Board approved the following grant of options pursuant toan agreement dated 3 January 2001, to Mr D.H Elgie a Director of the Company. The grant of options is as a result of the issue and allotment of new ordinaryshares relating to the issue of shares in connection with the acquisition of RedDoor Communications Limited. The details are as follows: Name Exercise No. of options Exercise period Price Don Elgie 31 August 2008 -30 August 2015 20,078 165.5p Of the options outlined above, 10,039 are performance related options, which canbe exercised after the initial exercise date provided Creston Plc's averagegrowth in diluted earnings per share has for two consecutive financial yearsexceeded the average growth in diluted earnings per share of such competitorcompanies (as specified by the Company's brokers) by greater than 10 per cent. In addition to the options outlined above, Mr Elgie has an interest in thefollowing: • 605,060 options over ordinary shares, at an exercise price of 95p • 382,380 options over ordinary shares, at an exercise price of 110p • 60,657 options over ordinary shares, at an exercise price of 114p • 91,145 options over ordinary shares, at an exercise price of 113p • 46,752 options over ordinary shares, at an exercise price of 139p • 6,930 options over ordinary shares, at an exercise price of 136p • 67,477 options over ordinary shares, at an exercise price of 142p • 487,280 options over ordinary shares, at an exercise price of 155p • 24,231 options over ordinary shares, at an exercise price of 165.5p In addition, the following awards were made to senior executives under theCreston plc Long Term Incentive Plan (the "Plan") in respect of 229,734 ordinaryshares of 10 pence each, which included the following awards made to Directorsand members of the Creston Operating Board. Name Position Number of ordinary shares Don Elgie Chief Executive 21,926 Keith Bates Managing Director, Marketing Sciences Group 43,729 Graham Monk Managing Director, TRA Limited 44,487 No payment was made for the grant of these awards and these shares will be heldby the Creston Employees Benefit Trust and will vest and be released to theaward holders for nil cost under the rules of the Plan. Subject to the rules ofthe Plan and the satisfaction of the performance conditions, these awards areanticipated to vest on the date of the announcement of the preliminary resultsof the Company in respect of the years ended 31 March 2007 and 2008. In addition to the award under the Plan outlined above, Mr. Bates and Mr Monkalso have a beneficial interest in 633,620 and 9,500 ordinary sharesrepresenting 1.73 per cent. and 0.03 per cent. of the issued ordinary sharecapital of the Company respectively. Mr Elgie also has a beneficial interest in997,801 ordinary shares in the Company representing 2.73 per cent of theCompany's issued ordinary share capital of the company. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Dec 20235:28 pmRNSPurchase of Shares by Employee Benefit Trust
30th Nov 20233:28 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20233:51 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20237:00 amRNSHolding(s) in Company
28th Nov 20234:41 pmRNSPurchase of Shares by Employee Benefit Trust
27th Nov 20233:17 pmRNSPurchase of Shares by Employee Benefit Trust
24th Nov 20232:02 pmRNSPurchase of Shares by Employee Benefit Trust
23rd Nov 20234:25 pmRNSPurchase of Shares by Employee Benefit Trust
22nd Nov 20235:06 pmRNSPurchase of Shares by Employee Benefit Trust
17th Nov 20234:20 pmRNSPurchase of Shares by Employee Benefit Trust
8th Nov 20237:00 amRNSDirectorate Change
8th Nov 20237:00 amRNSThird Quarter 2023 Trading Update
26th Oct 20237:00 amRNSNotice of Q3 2023 Trading Update and Webcast
25th Sep 20237:00 amRNSDirector/PDMR Shareholding
18th Aug 20237:00 amRNSDirector/PDMR Shareholding
18th Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
1st Aug 20233:59 pmRNSDirector/PDMR Shareholding
28th Jul 20237:00 amRNSDirector/PDMR Shareholding
27th Jul 20235:20 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSConduit Interim Results 2023
25th Jul 20237:00 amRNSDirectorate Change
14th Jul 20232:55 pmRNSNotice of H1 2023 Results and Conference Call
22nd Jun 20237:00 amRNSNotice of IFRS 17 Briefing Call
15th Jun 20234:48 pmRNSHolding(s) in Company
13th Jun 20237:00 amRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSTransfer of Treasury Shares
19th May 20234:56 pmRNSDirector/PDMR Shareholding
19th May 20237:00 amRNSDirector/PDMR Shareholding
18th May 20237:00 amRNSResults of 2023 AGM
17th May 20237:00 amRNSFirst Quarter 2023 Trading Update
4th May 20234:20 pmRNSNotice of Q1 2023 Trading Update and Webcast
17th Apr 20232:09 pmRNSNotice of AGM
6th Apr 20232:50 pmRNSHolding(s) in Company
3rd Apr 20237:00 amRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSHolding(s) in Company
7th Mar 20234:28 pmRNSDirector/PDMR Shareholding
6th Mar 202311:25 amRNSPublication of 2022 Annual Report and Accounts
22nd Feb 20237:00 amRNSYear ended 31 December 2022 Preliminary Results
17th Feb 20237:00 amRNSAppointment of Corporate Brokers
2nd Feb 20237:00 amRNSNotice of 2022 Results and Conference Call
25th Jan 20237:00 amRNSJanuary 2023 Renewals Trading Update
20th Jan 20232:00 pmRNSHolding(s) in Company
18th Jan 20237:00 amRNSNotice of 1 Jan 23 Renewals Trading Update Call

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.